Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Category: Media Commentary
-
By James DeGiulio — Earlier this summer, U.S. Patent and Trademark Office Director David Kappos announced a proposal for a three-tiered patent prosecution regime that could be instituted in the Office (see "USPTO Director Announces New Examination Options"). The new regime will provide for an accelerated examination track, a standard (status quo) track, and a…
-
By Kevin E. Noonan — It is apparent that the facts are often at risk or ignored by opponents of gene patenting. Indeed, the various forms of fact-twisting or outright falsehood ("corporations own your genes") suggests that it isn't facts that are at issue but opinions, and how the public's opinion on gene patenting…
-
By Kevin E. Noonan — The Internet over the past decade has given rise to a wide variety of "alternative media" outlets, including for example Slate, The Drudge Report, The Huffington Post, and arguably blogs like this one. Even conventional news outlets like The New York Times, The Washington Post, and The Wall Street…
-
By Kevin E. Noonan — Policy arguments based solely on outcome rather than process are rarely effective when put into practice. This is because the desired benefits of the outcome blind the policymaker to the question of whether the desired outcome can be achieved without considering the effects (intended or otherwise) by the process. …
-
By Kevin E. Noonan — Newsweek has always been Avis to Time Magazine's Hertz — evidenced by an increasing difference in subscriptions (3.3 million versus 1.97 million on 2009). So it isn't surprising that the magazine needs to do something to tweak its readership, even if that something is to distort its reporting on…
-
By Kevin E. Noonan — Fifteen hundred years ago everybody knew the Earth was the center of the universe. Five hundred years ago, everybody knew the Earth was flat, and fifteen minutes ago, you knew that humans were alone on this planet. Imagine what you'll know tomorrow. Men in Black (1997) And in 2010,…
-
Now, L.A. Times Gets It Wrong on Gene Patenting By Kevin E. Noonan — Maybe it is just the state of newspapers in the 21st Century — a 19th Century medium supplanted by technology that is more immediate, extensive, comprehensive, and relevant. Or maybe it is the pressure of deadlines and "getting the story,"…
-
The American Intellectual Property Law Association (AIPLA) will be holding its 2010 Mid-Winter Institute on January 27-30, 2010 in La Quinta, CA. The preliminary program for the Mid-Winter Institute includes presentations on the following topics: • Building strong IP on a smaller budget; • Business-based decision making and modeling for IP budgets;• Aligning patent filing…
-
By Donald Zuhn — Last month, the Milwaukee Journal Sentinel published two articles documenting the current state of the U.S. patent system (see "The Milwaukee Journal Sentinel Gets It Right about Patents"). The authors of those pieces, John Schmid and Ben Poston, have now compiled an interactive graphic that shows how the U.S. patent…
-
By Kevin E. Noonan — The fastest-growing part of the biotech/pharma industry is anticancer drugs, according to an article in The New York Times today ("For Profit, Industry Seeks Cancer Drugs"). Written by Andrew Pollack, one of the paper's senior business and technology writers, the article highlights the interplay between scientific interest and business…
Patent Docs 